Pyxis Oncology CSO Ronald Herbst resigns; Jan Pinkas promoted to CSO

Pyxis Oncology, Inc.

Ronald Herbst, Ph.D. resigned as CSO effective April 12, 2022; Mark Chin resigned from Board same day.
Jan Pinkas, Ph.D., formerly SVP Preclinical R&D, promoted to CSO effective April 12, 2022.
Company reaffirms IND filings for PYX-201 (Anti-EDB) and PYX-106 (Anti-Siglec-15) expected in 2H22.
Neither departure was due to any disagreement with the company or Board.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ronald Herbst

Chief Scientific Officer

PYXS · Pyxis Oncology, Inc.

Effective: 2022-04-12
Filed: April 14, 2022, 7:59 PM ET

On April 8, 2022, Ronald Herbst, Ph.D. resigned from his position with Pyxis Oncology, Inc. (the “Company”) as Chief Scientific Officer, effective on April 12, 2022.

Departed

Mark Chin

Director

PYXS · Pyxis Oncology, Inc.

Effective: 2022-04-12
Filed: April 14, 2022, 7:59 PM ET

On April 12, 2022, Mark Chin resigned from his position as a director of the board of directors (the “Board”) of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Herbst resigned as Chief Scientific Officer at Pyxis Oncology, Inc..

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

On April 8, 2022, Ronald Herbst, Ph.D. resigned from his position with Pyxis Oncology, Inc. (the “Company”) as Chief Scientific Officer, effective on April 12, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Chin resigned as Director at Pyxis Oncology, Inc..

Action: resigned
Role: Director

Exact text from the filing

On April 12, 2022, Mark Chin resigned from his position as a director of the board of directors (the “Board”) of the Company, effective immediately.

View on SEC.gov

Pyxis Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-105729

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.